ATE474574T1 - Imidazoazephinonverbindungen - Google Patents

Imidazoazephinonverbindungen

Info

Publication number
ATE474574T1
ATE474574T1 AT07795237T AT07795237T ATE474574T1 AT E474574 T1 ATE474574 T1 AT E474574T1 AT 07795237 T AT07795237 T AT 07795237T AT 07795237 T AT07795237 T AT 07795237T AT E474574 T1 ATE474574 T1 AT E474574T1
Authority
AT
Austria
Prior art keywords
compounds
imidazoazephinone
formula
treatment
methods
Prior art date
Application number
AT07795237T
Other languages
English (en)
Inventor
Mark Spyvee
Boris Seletsky
Shawn Schiller
Francis Fang
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of ATE474574T1 publication Critical patent/ATE474574T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07795237T 2006-05-26 2007-05-24 Imidazoazephinonverbindungen ATE474574T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80877006P 2006-05-26 2006-05-26
PCT/US2007/012298 WO2007139833A2 (en) 2006-05-26 2007-05-24 Imidazoazephinone compounds

Publications (1)

Publication Number Publication Date
ATE474574T1 true ATE474574T1 (de) 2010-08-15

Family

ID=38668997

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07795237T ATE474574T1 (de) 2006-05-26 2007-05-24 Imidazoazephinonverbindungen

Country Status (7)

Country Link
US (1) US7985746B2 (de)
EP (1) EP2021003B1 (de)
JP (1) JP2009538312A (de)
AT (1) ATE474574T1 (de)
DE (1) DE602007007934D1 (de)
ES (1) ES2347837T3 (de)
WO (1) WO2007139833A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007267983B2 (en) * 2006-05-26 2010-12-09 Eisai R&D Management Co., Ltd Imidazoazepinone compounds
US20090197867A1 (en) * 2007-11-15 2009-08-06 Mark Spyvee Enantiomerically enriched imidazoazepinone compounds
WO2009064431A1 (en) * 2007-11-15 2009-05-22 Eisai E & D Management Co., Ltd. Methods of use
CN101889014A (zh) * 2007-11-15 2010-11-17 卫材R&D管理有限公司 富含对映体的咪唑并吖庚因酮化合物
JP2011504878A (ja) * 2007-11-26 2011-02-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 イミダゾアゼピノン化合物の製造方法
CN102317289A (zh) * 2008-11-23 2012-01-11 辉瑞大药厂 作为β分泌酶抑制剂的内酰胺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2010742A1 (en) 1989-03-03 1990-09-03 Kenji Koga Azacyclooctadiene compound and pharmaceutical use
JPH04266886A (ja) 1991-02-20 1992-09-22 Eisai Co Ltd アザシクロオクタジエン誘導体
JP4710606B2 (ja) * 2003-04-18 2011-06-29 小野薬品工業株式会社 スピロピペリジン化合物およびその医薬用途
JP2008528005A (ja) 2005-01-20 2008-07-31 プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ Ｔ−ｂｅｔによるＴＨ２系譜コミットメントの調節
TW200724140A (en) 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds
AU2007267983B2 (en) * 2006-05-26 2010-12-09 Eisai R&D Management Co., Ltd Imidazoazepinone compounds

Also Published As

Publication number Publication date
EP2021003B1 (de) 2010-07-21
US7985746B2 (en) 2011-07-26
ES2347837T3 (es) 2010-11-04
US20090131405A1 (en) 2009-05-21
EP2021003A2 (de) 2009-02-11
WO2007139833A3 (en) 2008-01-31
WO2007139833A2 (en) 2007-12-06
JP2009538312A (ja) 2009-11-05
DE602007007934D1 (en) 2010-09-02

Similar Documents

Publication Publication Date Title
EA201100037A1 (ru) Органические соединения
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201170832A1 (ru) Пуриновые соединения
EA200901133A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
EA201170772A1 (ru) Органические соединения
UA110612C2 (uk) Похідні 1-аміно-2-циклопропілетилборонової кислоти
EA200970156A1 (ru) Пиридизиноновые производные
BRPI0915084B8 (pt) composto, e, composição farmacêutica
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
EA200901138A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
EA201300684A1 (ru) Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
CY1113102T1 (el) Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA200801997A1 (ru) Новые соединения
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
EA201170531A1 (ru) Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
GB0625648D0 (en) Compounds
UY31065A1 (es) Heterociclos ciclicos
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
UA109290C2 (uk) Спільні кристали і солі інгібіторів ccr3

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties